InvestorsHub Logo
Followers 6
Posts 1084
Boards Moderated 0
Alias Born 07/18/2006

Re: biotech_researcher post# 5233

Thursday, 08/17/2017 5:03:24 PM

Thursday, August 17, 2017 5:03:24 PM

Post# of 17395
I can't add anything new.....I'm just referencing what we already know that has been posted here.

Lunacy's recent post is a powerful testament:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133929107

I'm in repetition mode here, but the short list of AUPH's advantages are:

Stellar management team, great science, Aspreva success, stellar VOC P2 results, expertise in trial design, FDA Fast Track status, etc.

I simply believe that when you add it all up, it significantly boosts their odds of success in P3.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News